| The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada M Brisson, N Van de Velde, P De Wals, MC Boily Vaccine 25 (29), 5399-5408, 2007 | 220 | 2007 |
| Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ... The Lancet 387 (10016), 367-375, 2016 | 216 | 2016 |
| Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis N Van de Velde, MC Boily, M Drolet, EL Franco, MH Mayrand, EV Kliewer, ... Journal of the National Cancer Institute 104 (22), 1712-1723, 2012 | 171 | 2012 |
| Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity M Brisson, N van de Velde, EL Franco, M Drolet, MC Boily Journal of Infectious Diseases 204 (3), 372-376, 2011 | 143 | 2011 |
| Economic evaluation of human papillomavirus vaccination in developed countries M Brisson, N Van de Velde, MC Boily Public health genomics 12 (5-6), 343-351, 2009 | 142 | 2009 |
| Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty N Van de Velde, M Brisson, MC Boily American journal of epidemiology 165 (7), 762-775, 2007 | 140 | 2007 |
| Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis N Van de Velde, M Brisson, MC Boily Vaccine 28 (33), 5473-5484, 2010 | 116 | 2010 |
| Undetectable equals untransmittable (U= U): awareness and associations with health outcomes among people living with HIV in 25 countries C Okoli, N Van de Velde, B Richman, B Allan, E Castellanos, B Young, ... Sexually transmitted infections 97 (1), 18-26, 2021 | 110 | 2021 |
| Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection M Brisson, N Van de Velde, P De Wals, MC Boily Cmaj 177 (5), 464-468, 2007 | 89 | 2007 |
| Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study M Brisson, JF Laprise, M Drolet, N Van de Velde, EL Franco, EV Kliewer, ... Vaccine 31 (37), 3863-3871, 2013 | 74 | 2013 |
| Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries P de Los Rios, C Okoli, Y Punekar, B Allan, M Muchenje, E Castellanos, ... Preventive Medicine 139, 106182, 2020 | 45 | 2020 |
| Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model E Delgleize, O Leeuwenkamp, E Theodorou, N Van de Velde BMJ open 6 (11), e010776, 2016 | 45 | 2016 |
| Physical, emotional, and psychosocial challenges associated with daily dosing of HIV medications and their impact on indicators of quality of life: findings from the positive … P de Los Rios, C Okoli, E Castellanos, B Allan, B Young, G Brough, ... AIDS and Behavior 25, 961-972, 2021 | 44 | 2021 |
| Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11 M Brisson, N Van de Velde, MC Boily Sexually transmitted infections 87 (1), 41-43, 2011 | 39 | 2011 |
| Shared decision making between patients and healthcare providers and its association with favorable health outcomes among people living with HIV C Okoli, G Brough, B Allan, E Castellanos, B Young, A Eremin, ... AIDS and Behavior 25, 1384-1395, 2021 | 35 | 2021 |
| Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries B Akinwunmi, D Buchenberger, J Scherzer, M Bode, P Rizzini, F Vecchio, ... Sexually transmitted infections 97 (8), 566-573, 2021 | 22 | 2021 |
| The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis T Malagón, V Joumier, MC Boily, N Van de Velde, M Drolet, M Brisson Vaccine 31 (13), 1740-1747, 2013 | 22 | 2013 |
| Potential public health impact of RTS, S malaria candidate vaccine in sub-Saharan Africa: a modelling study CJ Sauboin, LA Van Bellinghen, N Van De Velde, I Van Vlaenderen Malaria Journal 14, 1-17, 2015 | 19 | 2015 |
| Treatment aspirations and attitudes towards innovative medications among people living with HIV in 25 countries P de los Rios, C Okoli, B Young, B Allan, E Castellanos, G Brough, ... Population Medicine 2 (July), 2020 | 18 | 2020 |
| Economic impact of introducing the RTS, S malaria vaccine: cost-effectiveness and budget impact analysis in 41 countries C Sauboin, LA Van Bellinghen, N Van De Velde, I Van Vlaenderen MDM Policy & Practice 4 (2), 2381468319873324, 2019 | 18 | 2019 |
